To Top
The pandemic’s silent saviours

The pandemic’s silent saviours

01 October 2021

We salute the scientists who’ve been working behind the scenes, combating the coronavirus

Know more
Govt lauds Indian Immunologicals for producing Covid-19 vaccine drug substance in record time

Govt lauds Indian Immunologicals for producing Covid-19 vaccine drug substance in record time

24 September 2021

Hyderabad: Union Fisheries, Animal Husbandry, and Dairying minister Parshottam Rupala lauded the efforts of Indian Immunologicals Limited (IIL) for its ability to roll out Covid-19 vaccine drug substance in record time.

Know more
Union Minister Parshottam Rupala lauds IIL for producing COVID-19 drug substance in record time

Union Minister Parshottam Rupala lauds IIL for producing COVID-19 drug substance in record time

24 September 2021

New Delhi [India], September 24 (ANI): Union Fisheries, Animal Husbandry, and Dairying Minister, Parshottam Rupala lauded the efforts of Indian Immunologicals Limited (IIL) for their ability to roll out the COVID-19 vaccine drug substance in record time.

Know more
Govt lauds IIL, BBIL's effort in COVID-19 vaccine production

Govt lauds IIL, BBIL's effort in COVID-19 vaccine production

24 September 2021

Union Fisheries, Animal Husbandry, and Dairying Minister, Parshottam Rupala hands over COVID-19 drug substance made at IIL to Dr Krishna Ella, CMD, BBIL

Know more
Indian Immunologicals to ramp up production of input for Covaxin

Indian Immunologicals to ramp up production of input for Covaxin

24 September 2021

This was disclosed by the Hyderabad-based IIL during the visit of Union Minister Parshottam Rupala

Know more
Union Minister Parshottam Rupala lauds IIL for producing COVID-19 drug substance in record time

Union Minister Parshottam Rupala lauds IIL for producing COVID-19 drug substance in record time

24 September 2021

New Delhi [India], September 24 (ANI): Union Fisheries, Animal Husbandry, and Dairying Minister, Parshottam Rupala lauded the efforts of Indian Immunologicals Limited (IIL) for their ability to roll out the COVID-19 vaccine drug substance in record time.

Know more
Indian Immunologicals Limited to make 10 million doses of Covaxin drug substance from Dec

Indian Immunologicals Limited to make 10 million doses of Covaxin drug substance from Dec

24 September 2021

Indian Immunologicals Limitedis also developing on a live attenuated COVID-19 vaccine which has many advantages and will be rolled out next year.

Know more
IHWDigitalHealth Awards 2021

IHWDigitalHealth Awards 2021

19 August 2021

Human Biologicals Institute (A division of Indian Immunologicals Limited) has received the gold award in the category of “Communication Solutions” in the IHWDigitalHealth Awards 2021 for its public awareness initiative "Fearless against rabies"

Know more
IIL starts Covaxin drug substance supply to Bharat Bio for 3-4 million doses per month

IIL starts Covaxin drug substance supply to Bharat Bio for 3-4 million doses per month

13 August 2021

HYDERABAD: In a move that will immediately augment the production capacity of indigenously developed Covid-19 Covaxin, Indian Immunologicals Ltd (IIL) on Friday handed over the first batch of the Covaxin drug substance to Bharat Biotech.

Know more
Veterinary and human vaccines maker, Indian Immunologicals Limited (IIL), has launched the Classical Swine Fever (CSF) vaccine under the brand name ‘Raksha Class’

Veterinary and human vaccines maker, Indian Immunologicals Limited (IIL), has launched the Classical Swine Fever (CSF) vaccine under the brand name ‘Raksha Class’

03 June 2020

Veterinary and human vaccines maker, Indian Immunologicals Limited (IIL), has launched the Classical Swine Fever (CSF) vaccine under the brand name ‘Raksha Class’.

Know more
The vaccine is expected to provide long-lasting protection with a single dose administration with an anticipated safety profile similar to other licensed vaccines for active immunization

The vaccine is expected to provide long-lasting protection with a single dose administration with an anticipated safety profile similar to other licensed vaccines for active immunization

08 April 2020

Vaccine manufacturer Indian Immunologicals Ltd (IIL) has entered into a research collaboration agreement with Australia’s Griffith University to develop a lead vaccine candidate for Coronavirus.

Know more
As part of the agreement, scientists from Indian Immunologicals and Griffith University will develop a ‘Live Attenuated SARS – CoV-2 vaccine’

As part of the agreement, scientists from Indian Immunologicals and Griffith University will develop a ‘Live Attenuated SARS – CoV-2 vaccine’

07 April 2020

Vaccine maker Indian Immunologicals Limited (IIL), is going to commence research for developing a vaccine for Corona Virus (COVID-19).

Know more
 Human Biologicals Institute launches Eco Friendly Pack for its Anti Rabies Vaccine ‘Abhayrab’

Human Biologicals Institute launches Eco Friendly Pack for its Anti Rabies Vaccine ‘Abhayrab’

08 January 2020

The new packaging of Abhayrab is manufactured using only paper-based materials which helps in reducing the carbon footprint as well.

Know more
IIL organises animal vaccination camps

IIL organises animal vaccination camps

10 July 2019

Around 50,000 free doses administered by IIL at 170+ Vaccination camps in 20 States & UTs

Know more
Free animal vaccination camps across India by Indian Immunologicals on ‘World Zoonosis Day’

Free animal vaccination camps across India by Indian Immunologicals on ‘World Zoonosis Day’

09 July 2019

Kolkata, Jul 09 (UNI) Indian Immunologicals Limited (IIL), a leading biologicals company, today organized free Vaccination Camps in over 170 centres across the country.

Know more
Indian Immunologicals to invest Rs 75 cr in sterile facility in Hyderabad

Indian Immunologicals to invest Rs 75 cr in sterile facility in Hyderabad

24 June 2019

Indian Immunologicals Ltd (IIL), a biologicals company, will invest Rs 75 crore in a new Sterile Filing Facility (SFF), in Phase 3 of the Genome Valley on the outskirts of Hyderabad.

Know more
Indian Immunologicals launches VAXTAR 5

Indian Immunologicals launches VAXTAR 5

27 March 2019

Indian Immunologicals Limited has launched VAXTAR 5, Pentavalent vaccine for the children. IIL is all set to make this vaccine in its state-of-the-art vaccine manufacturing facility in Hyderabad for retail market and for the national “Universal Immunisation Programme” (UIP) implemented by Ministry of Health and Family Welfare (MOHFW), Government of India.

Know more
Indian Immunologicals launches herbal product for animals Indian Immunologicals launches herbal product for animals - The Hindu BusinessLine

Indian Immunologicals launches herbal product for animals Indian Immunologicals launches herbal product for animals - The Hindu BusinessLine

09 January 2018

Indian Immunologicals Ltd (IIL) has launched its first herbal product ‘Zuspray’ for animals.

It marks the entry of the company, which is a leading player in animal health products, into the Rs 480-crore domestic animal health herbal market.

Know more
Indian manufacturers account for 60% of vaccine supplies made to UNICEF

Indian manufacturers account for 60% of vaccine supplies made to UNICEF

22 August 2017

‘Indian vaccine manufacturers have several products in their R&D pipeline and as they roll out, the dominance of the multinational companies will subside in the coming years’, says Dr Anand Kumar Managing Director Indian Immunologicals Ltd & Director Pristine Biologicals (NZ) Ltd, in an interaction with BioSpectrum Asia Magazine

Know more
Indian Immunologicals develops vaccine to fight tapeworms in pigs

Indian Immunologicals develops vaccine to fight tapeworms in pigs

25 October 2016

Immunologicals Limited (IIL) has launched CYSVAX, which the company claims to be the world’s first vaccine to fight tapeworms in pigs.

Know more